Sun Pharmaceutical Industries is sharpening its focus on research and development, regulatory compliance, and manufacturing capabilities as it targets high single-digit consolidated revenue growth in FY27, Chairman Dilip Shanghvi said during the company’s latest earnings call. The pharmaceutical major continues to invest heavily in strengthening both its global generics and innovative medicines businesses, with R&D […]